David Hoang

Stock Analyst at Deutsche Bank

(0)
# 4547
Out of 5,326 analysts
43
Total ratings
24.00%
Success rate
-17.30%
Average return
21 Stocks
Name Action Price Target Current % Upside Ratings Updated
ALKS Alkermes
Maintains: Strong Buy
40 52
27.7 87.73% 2 Mar 27, 2025
SRPT Sarepta Therapeutics
Maintains: Hold
124 99
61.86 60.04% 6 Mar 19, 2025
XENE Xenon Pharmaceutical...
Initiates Coverage On: Buy
67
38.23 75.26% 3 Feb 11, 2025
PRAX Praxis Precision Med...
Initiates Coverage On: Buy
111
35.9 209.19% 1 Feb 11, 2025
HRMY Harmony Biosciences
Initiates Coverage On: Buy
55
29.46 86.69% 2 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
31
15.51 99.87% 3 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
65
23.38 178.02% 1 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
176
105.38 67.01% 4 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
8.6 39.53% 1 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
30 23
14.82 55.2% 4 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
150 158
105.82 49.31% 4 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
45 50
n/a n/a 3 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
7
1.1 536.36% 1 Jul 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
8
7.79 2.7% 1 May 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
3.67 335.97% 1 Mar 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
3.54 351.98% 1 Mar 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
220
242.32 -9.21% 1 Apr 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
80
13.36 498.8% 1 Apr 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
15 25
n/a n/a 1 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3
0.97 209.28% 1 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Apr 1, 2022